Nutromics unveils world-first real-time multiplexed antibiotic monitoring breakthrough
Nutromics has announced a major milestone in wearable diagnostics, unveiling the world’s first real-time, continuous in vivo data for two antibiotics—vancomycin and tobramycin—measured simultaneously on a single device. The breakthrough was presented at the International Congress of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) in Singapore.
The study, conducted in rats, demonstrated Nutromics’ platform could continuously track multiple drug levels in real time using its Lab-on-a-Patch® technology. The microneedle-based device enabled the simultaneous monitoring of vancomycin and tobramycin, both frontline antibiotics used to treat severe infections such as sepsis and MRSA. The company said the innovation could help clinicians optimise dosing to improve patient safety and reduce antimicrobial resistance.
